Aethlon Medical, Inc. – NASDAQ:AEMD

Aethlon Medical stock price today

$1.12
+0.51
+84.94%
Financial Health
0
1
2
3
4
5
6
7
8
9

Aethlon Medical stock price monthly change

+42.55%
month

Aethlon Medical stock price quarterly change

+42.55%
quarter

Aethlon Medical stock price yearly change

-70.86%
year

Aethlon Medical key metrics

Market Cap
8.10M
Enterprise value
N/A
P/E
-0.53
EV/Sales
-572.30
EV/EBITDA
0.56
Price/Sales
664.81
Price/Book
0.50
PEG ratio
0.05
EPS
-6.09
Revenue
N/A
EBITDA
-11.11M
Income
-11.19M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
-101768.29%
Oper. margin
-78965.29%
Gross margin
0%
EBIT margin
-78965.29%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

Aethlon Medical stock price history

Aethlon Medical stock forecast

Aethlon Medical financial statements

Aethlon Medical, Inc. (NASDAQ:AEMD): Profit margin
Dec 2021 17.11K -2.52M -14755.69%
Mar 2022 13.11K -3.78M -28858.48%
Mar 2023 574.24K -2.45M -427.69%
Mar 2024 0 -2.42M
Aethlon Medical, Inc. (NASDAQ:AEMD): Analyst Estimates
2026 125.5M -1.25M -1%
  • Analysts Price target

  • Financials & Ratios estimates

Aethlon Medical, Inc. (NASDAQ:AEMD): Debt to assets
Sep 2022 23047199 3.17M 13.79%
Dec 2022 20724499 3.44M 16.62%
Mar 2023 17508940 2.44M 13.96%
Mar 2024 8245982 2.47M 30.07%
Aethlon Medical, Inc. (NASDAQ:AEMD): Cash Flow
Dec 2021 -2.71M -57.93K -13.55K
Mar 2022 -3.09M -212.39K -10.64K
Mar 2023 -2.94M -11.28K -2.63K
Mar 2024 -2.56M -4.90K 42.57K

Aethlon Medical alternative data

Aethlon Medical, Inc. (NASDAQ:AEMD): Employee count
Aug 2023 15
Sep 2023 15
Oct 2023 15
Nov 2023 15
Dec 2023 15
Jan 2024 15
Feb 2024 15
Apr 2024 15
May 2024 15
Jun 2024 15
Jul 2024 14

Aethlon Medical other data

1.50% -4.74%
of AEMD is owned by hedge funds
345.25K -950.68K
shares is hold by hedge funds

Aethlon Medical, Inc. (NASDAQ:AEMD): Insider trades (number of shares)
Period Buy Sel
Dec 2020 0 53704
Transaction Date Insider Security Shares Price per share Total value Source
Sale
SHAH CHETAN director
Common Stock 26,852 $0.7 $18,716
Sale
SHAH CHETAN director
Common Stock 26,852 $2.1 $56,362
Option
KENLEY RODNEY S director, officer: President
Common Stock 1,768 $1.04 $1,839
Option
JOYCE JAMES A director, officer: Chairman, CE..
Common Stock 18,683 $1.04 $19,430
Option
FRAKES JAMES B officer: Chief Financial Officer
Common Stock 1,532 $1.04 $1,593
Option
FRAKES JAMES B officer: Chief Financial Officer
Common Stock 1,562 $1.23 $1,921
Option
KENLEY RODNEY S director, officer: President
Common Stock 1,797 $1.23 $2,210
Option
JOYCE JAMES A director, officer: Chairman, CE..
Common Stock 18,683 $1.23 $22,980
Option
KENLEY RODNEY S director, officer: President
Common Stock 1,596 $1.34 $2,139
Option
FRAKES JAMES B officer: Chief Financial Officer
Common Stock 1,328 $1.34 $1,780
Patent
Application
Filling date: 9 Apr 2021 Issue date: 2 Dec 2021
Application
Filling date: 31 Jul 2018 Issue date: 25 Feb 2021
Application
Filling date: 1 Jul 2019 Issue date: 28 May 2020
Application
Filling date: 17 May 2019 Issue date: 2 Apr 2020
Insider Compensation
Dr. Charles J. Fisher Jr., M.D. (1947) Chief Executive Officer, Director & Member of Extracorporeal Therapy Advisory Board $509,140
Mr. James B. Frakes M.B.A. (1957) Chief Financial Officer, Senior Vice President of Fin. & Sec.
$385,000
Mr. Guy F. Cipriani BS (Eng.), MBA (1970) Senior Vice President, Chief Bus. Officer & Director
$29,750
Friday, 20 December 2024
prnewswire.com
Thursday, 14 November 2024
newsfilecorp.com
Wednesday, 13 November 2024
seekingalpha.com
prnewswire.com
Tuesday, 12 November 2024
newsfilecorp.com
Monday, 11 November 2024
prnewswire.com
Wednesday, 6 November 2024
prnewswire.com
Tuesday, 8 October 2024
prnewswire.com
Thursday, 19 September 2024
newsfilecorp.com
prnewswire.com
Tuesday, 17 September 2024
prnewswire.com
newsfilecorp.com
Monday, 16 September 2024
prnewswire.com
Friday, 13 September 2024
globenewswire.com
Tuesday, 27 August 2024
prnewswire.com
Wednesday, 14 August 2024
seekingalpha.com
prnewswire.com
Monday, 12 August 2024
newsfilecorp.com
prnewswire.com
Tuesday, 6 August 2024
prnewswire.com
Thursday, 27 June 2024
seekingalpha.com
prnewswire.com
Friday, 21 June 2024
prnewswire.com
Thursday, 20 June 2024
newsfilecorp.com
Tuesday, 18 June 2024
prnewswire.com
Friday, 7 June 2024
newsfilecorp.com
Thursday, 6 June 2024
investorplace.com
Monday, 3 June 2024
newsfilecorp.com
prnewswire.com
Wednesday, 15 May 2024
prnewswire.com
  • What's the price of Aethlon Medical stock today?

    One share of Aethlon Medical stock can currently be purchased for approximately $1.12.

  • When is Aethlon Medical's next earnings date?

    Unfortunately, Aethlon Medical's (AEMD) next earnings date is currently unknown.

  • Does Aethlon Medical pay dividends?

    No, Aethlon Medical does not pay dividends.

  • How much money does Aethlon Medical make?

    Aethlon Medical has a market capitalization of 8.10M.

  • What is Aethlon Medical's stock symbol?

    Aethlon Medical, Inc. is traded on the NASDAQ under the ticker symbol "AEMD".

  • What is Aethlon Medical's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of Aethlon Medical?

    Shares of Aethlon Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are Aethlon Medical's key executives?

    Aethlon Medical's management team includes the following people:

    • Dr. Charles J. Fisher Jr., M.D. Chief Executive Officer, Director & Member of Extracorporeal Therapy Advisory Board(age: 78, pay: $509,140)
    • Mr. James B. Frakes M.B.A. Chief Financial Officer, Senior Vice President of Fin. & Sec.(age: 68, pay: $385,000)
    • Mr. Guy F. Cipriani BS (Eng.), MBA Senior Vice President, Chief Bus. Officer & Director(age: 55, pay: $29,750)
  • How many employees does Aethlon Medical have?

    As Jul 2024, Aethlon Medical employs 14 workers, which is 7% less then previous month and 7% less then previous quarter.

  • When Aethlon Medical went public?

    Aethlon Medical, Inc. is publicly traded company for more then 26 years since IPO on 4 Mar 1999.

  • What is Aethlon Medical's official website?

    The official website for Aethlon Medical is aethlonmedical.com.

  • Where are Aethlon Medical's headquarters?

    Aethlon Medical is headquartered at 11555 Sorrento Valley Road, San Diego, CA.

  • How can i contact Aethlon Medical?

    Aethlon Medical's mailing address is 11555 Sorrento Valley Road, San Diego, CA and company can be reached via phone at +61 99410360.

Aethlon Medical company profile:

Aethlon Medical, Inc.

aethlonmedical.com
Exchange:

NASDAQ

Full time employees:

14

Industry:

Medical - Devices

Sector:

Healthcare

Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company develops Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses from the human circulatory system, including removal of COVID-19 virus, associated variants, and related exosomes. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh Medical Center Hillman Cancer Center for studies related to head and neck cancer. The company was founded in 1999 and is based in San Diego, California.

11555 Sorrento Valley Road
San Diego, CA 92121

CIK: 0000882291
ISIN: US00808Y4061
CUSIP: 00808Y307